Hideyuki Kato1, Yaqin Yana Fu1, Jiaquan Zhu1, Lixing Wang1, Shabana Aafaqi1, Otto Rahkonen2, Cameron Slorach2, Alexandra Traister1, Chung Ho Leung1, David Chiasson3, Luc Mertens2, Lee Benson2, Richard D Weisel4, Boris Hinz5, Jason T Maynes6, John G Coles1, Christopher A Caldarone7. 1. Division of Cardiovascular Surgery, Hospital for Sick Children, Labatt Family Heart Center and University of Toronto, Toronto, Ontario, Canada. 2. Division of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada. 3. Division of Pathology and Paediatric Laboratory Medicine, Laboratory of Tissue Repair and Regeneration, University of Toronto, Hospital for Sick Children, Toronto, Ontario, Canada. 4. Division of Cardiac Surgery, Toronto General Hospital, Toronto, Ontario, Canada. 5. Laboratory of Tissue Repair and Regeneration, Matrix Dynamics Group, Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada. 6. Division of Anaesthesia and Pain Medicine and Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario, Canada. 7. Division of Cardiovascular Surgery, Hospital for Sick Children, Labatt Family Heart Center and University of Toronto, Toronto, Ontario, Canada. Electronic address: christopher.caldarone@sickkids.ca.
Abstract
BACKGROUND: Surgical and catheter-based interventions on pulmonary veins are associated with pulmonary vein stenosis (PVS), which can progress diffusely through the "upstream" pulmonary veins. The mechanism has been rarely studied. We used a porcine model of PVS to assess disease progression with emphasis on the potential role of endothelial-mesenchymal transition (EndMT). METHODS: Neonatal piglets underwent bilateral pulmonary vein banding (banded, n = 6) or sham operations (sham, n = 6). Additional piglets underwent identical banding and stent implantation in a single-banded pulmonary vein 3 weeks postbanding (stented, n = 6). At 7 weeks postbanding, hemodynamics and upstream PV pathology were assessed. RESULTS: Banded piglets developed pulmonary hypertension. The upstream pulmonary veins exhibited intimal thickening associated with features of EndMT, including increased transforming growth factor (TGF)-β1 and Smad expression, loss of endothelial and gain of mesenchymal marker expression, and coexpression of endothelial and mesenchymal markers in banded pulmonary vein intimal cells. These immunopathologic changes and a prominent myofibroblast phenotype in the remodeled pulmonary veins were consistently identified in specimens from patients with PVS, in vitro TGF-β1-stimulated cells isolated from piglet and human pulmonary veins, and human umbilical vein endothelial cells. After stent implantation, decompression of a pulmonary vein was associated with reappearance of endothelial marker expression, suggesting the potential for plasticity in the observed pathologic changes, followed by rapid in-stent restenosis. CONCLUSIONS: Neonatal pulmonary vein banding in piglets recapitulates critical aspects of clinical PVS and highlights a pathologic profile consistent with EndMT, supporting the rationale for evaluating therapeutic strategies designed to exploit reversibility of upstream pulmonary vein pathology.
BACKGROUND: Surgical and catheter-based interventions on pulmonary veins are associated with pulmonary vein stenosis (PVS), which can progress diffusely through the "upstream" pulmonary veins. The mechanism has been rarely studied. We used a porcine model of PVS to assess disease progression with emphasis on the potential role of endothelial-mesenchymal transition (EndMT). METHODS: Neonatal piglets underwent bilateral pulmonary vein banding (banded, n = 6) or sham operations (sham, n = 6). Additional piglets underwent identical banding and stent implantation in a single-banded pulmonary vein 3 weeks postbanding (stented, n = 6). At 7 weeks postbanding, hemodynamics and upstream PV pathology were assessed. RESULTS: Banded piglets developed pulmonary hypertension. The upstream pulmonary veins exhibited intimal thickening associated with features of EndMT, including increased transforming growth factor (TGF)-β1 and Smad expression, loss of endothelial and gain of mesenchymal marker expression, and coexpression of endothelial and mesenchymal markers in banded pulmonary vein intimal cells. These immunopathologic changes and a prominent myofibroblast phenotype in the remodeled pulmonary veins were consistently identified in specimens from patients with PVS, in vitro TGF-β1-stimulated cells isolated from piglet and humanpulmonary veins, and human umbilical vein endothelial cells. After stent implantation, decompression of a pulmonary vein was associated with reappearance of endothelial marker expression, suggesting the potential for plasticity in the observed pathologic changes, followed by rapid in-stent restenosis. CONCLUSIONS:Neonatal pulmonary vein banding in piglets recapitulates critical aspects of clinical PVS and highlights a pathologic profile consistent with EndMT, supporting the rationale for evaluating therapeutic strategies designed to exploit reversibility of upstream pulmonary vein pathology.
Authors: David B Frank; Philip T Levy; Corey A Stiver; Brian A Boe; Christopher W Baird; Ryan M Callahan; Charles V Smith; Rachel D Vanderlaan; Carl H Backes Journal: J Perinatol Date: 2021-03-05 Impact factor: 2.521
Authors: Vincent Sarrazy; Anne Koehler; Melissa L Chow; Elena Zimina; Chen X Li; Hideyuki Kato; Christopher A Caldarone; Boris Hinz Journal: Cardiovasc Res Date: 2014-03-17 Impact factor: 10.787
Authors: Krishna K Singh; Fina Lovren; Yi Pan; Adrian Quan; Azza Ramadan; Pratiek N Matkar; Mehroz Ehsan; Paul Sandhu; Laura E Mantella; Nandini Gupta; Hwee Teoh; Matteo Parotto; Arata Tabuchi; Wolfgang M Kuebler; Mohammed Al-Omran; Toren Finkel; Subodh Verma Journal: J Biol Chem Date: 2014-12-19 Impact factor: 5.157
Authors: Martin L Tomov; Alexander Cetnar; Katherine Do; Holly Bauser-Heaton; Vahid Serpooshan Journal: J Am Heart Assoc Date: 2019-12-10 Impact factor: 5.501